• Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar
  • Skip to footer
MS Money Moves

MS Money Moves

Striving to raise financial literacy amongst today’s youth and providing top tier equity analysis

  • Home
  • Articles
  • News
  • About us
  • Performance Record
  • Become a contributor
  • Contact

$VSTM

Morning Update-Form 13G’s On Deck!

February 8, 2019 by Lucien Dale 1 Comment

Leave a comment and click here to sub for MS Equity Analysis and Swing Moves. Good Morning! We hope you all are enjoying your early morning trading! Today, three companies we … [Read more...] about Morning Update-Form 13G’s On Deck!

Filed Under: Market Updates Tagged With: $VSTM, filings, SEC, TRVN

State Street Corp’s Amended 13G/A Reveals 11.53% Ownership of VSTM

January 10, 2019 by Zion Miller Leave a Comment

Leave a comment and click here to subscribe for MS article alerts and our newsletter! Overview January 10th, in an Amended 13G/A, Street Corp updated their reported holdings in VSTM to … [Read more...] about State Street Corp’s Amended 13G/A Reveals 11.53% Ownership of VSTM

Filed Under: Market Updates Tagged With: $VSTM, Company Updates, Oncology

Wednesday Pre-market Movers

January 9, 2019 by Sultan Leave a Comment

01/09/2019 Leave a comment and click here to subscribe for MS article alerts and our newsletter! Verastem Oncology (Nasdaq: VSTM) is up 7.18% on trading at $4.33 on moderate volume of … [Read more...] about Wednesday Pre-market Movers

Filed Under: Market Updates Tagged With: $VSTM, arql, ArQule, BAL087, Basailea Pharmacetical, Company Updates, copiktra, derazantinib, Oncology, Verestem Oncology

VSTM- A Reduced Risk Oncology Company

December 25, 2018 by Zion Miller 5 Comments

Leave a comment and click here to sub for MS article alerts and our newsletter  Introduction Investors and watchers of VSTM were elated to receive positive news from the FDA in late September … [Read more...] about VSTM- A Reduced Risk Oncology Company

Filed Under: Equity Analysis Tagged With: $VSTM, blood cancer, CPSC Pharmaceutical Group, Oncology

Potentially Lucrative Opportunities Amidst A Stock Market Bloodbath

October 25, 2018 by Sultan 1 Comment

Overview Wednesday October 24th, 2018 the stock market was slashed across the board with the DOW erasing all its gains for the year and dripping red. The Nasdaq was hit with equal force. Comments from … [Read more...] about Potentially Lucrative Opportunities Amidst A Stock Market Bloodbath

Filed Under: Market Updates, Swing Trades Tagged With: $ADMP, $NVS, $VSTM, AcelRX Pharmaceuticals, ACRX, ADMA, Adma Biologics, Admais, allergies, anaphylaxis, asthma, AVEO, binary catalyst, biotech stocks, Blood, blood cancer, bloodbath, buyout, Cancer, Cirrhosis, COPD, day trading, DSUVIA, Epipen, Fibrotic diseases, FL SL CLL cancer, Galetin Therapeutics, GALT, IG, IGs, Immunoglobulins, iNHL, invest, investing, investors, IVIG, IVIGs, money, MS Picks November 2018, Naloxone, NASH, NDA, new drug application, NHL, Novartis, Oncology, onocology, opioid, opioid epidemic, pdufa, personal finance, PI, PIDD, plasma, Sandoz, SELB, Specialty Pharmaceuticals, stock market, stocks, sufentanil, swing trading, technical analysis, TRVN, TXMD, Verastem, Verestem Oncology, zalviso

VSTM Overaction to Black Box Label Creates Buying Opportunity

September 26, 2018 by Sultan 2 Comments

For months Verastem Oncology (VSTM) investors have been eagerly awaiting the FDA's decision on it's lead product Duvelisib; a PI3K-δ (delta) and PI3K-γ (gamma) inhibitor that was granted Orphan Drug … [Read more...] about VSTM Overaction to Black Box Label Creates Buying Opportunity

Filed Under: Equity Analysis Tagged With: $VSTM, binary catalyst, biotech stocks, blood cancer, Cancer, day trading, FL SL CLL cancer, Galetin Therapeutics, iNHL, invest, investing, investors, money, NHL, Oncology, pdufa, stock market, stocks, swing trading, technical analysis, Verastem, Verestem Oncology

Primary Sidebar

Categories

  • Market Updates
  • Equity Analysis
  • Swing Trades
  • Education
  • Interviews

MS Watchlist

MS Watchlist by TradingView
Advertisements

Sub for MS updates!

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Advertisements

Follow us!

  • Twitter
  • Facebook
  • Instagram
  • YouTube

Footer

MS Money Moves

  • Home
  • Articles
  • News
  • About us
  • Performance Record
  • Become a contributor
  • Contact

Categories

  • Market Updates
  • Equity Analysis
  • Swing Trades
  • Education
  • Interviews

Become a contributor

MS Money Moves would like to offer you the opportunity to express your unique perspective regarding publicly traded companies via our website.

All we ask is you write clearly, concisely, and have original ideas. Interested? Contact us now.

Sub for MS updates!

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Follow Us

  • Twitter
  • Facebook
  • Instagram
  • YouTube

© 2019 · MS Money Moves